Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?

Abstract

Lei Zhao1 and Wu Zhong1,* 1National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China *Correspondence: [email protected] Received: May 3, 2021; Accepted: September 6, 2021; Published Online: September 8, 2021; https://doi.org/10.1016/j.xinn.2021.100165 a 2021 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Citation: Zhao L. and Zhong W. (2021). Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination? The Innovation 2(4), 100165.